(25 days)
Not Found
No
The device description and performance studies focus on the mechanical and material properties of a balloon catheter, with no mention of AI or ML.
Yes.
The device is intended to dilate stenoses and treat obstructive lesions in various arteries, which directly addresses a medical condition or disease by restoring proper blood flow.
No
Explanation: The device is a PTA balloon intended to dilate stenoses and treat obstructive lesions, which are therapeutic actions, not diagnostic.
No
The device description clearly details a physical catheter with a balloon, scoring wires, radiopaque markers, and lumens, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device used in vivo (within the body) to dilate blood vessels and treat lesions. IVDs are used in vitro (outside the body) to examine specimens like blood, urine, or tissue to diagnose diseases or conditions.
- Device Description: The description details a physical catheter with a balloon and scoring wires designed for insertion into the body. This is consistent with an interventional medical device, not an IVD.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, or any of the typical components or functions of an IVD.
Therefore, the UltraScore Focused Force PTA Balloon is a therapeutic medical device used for interventional procedures, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The UltraScore Focused Force PTA Balloon is intended to dilate stenoses in the iliac, femoral, popliteal, infra-popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also recommended for post dilatation of balloon expandable stents, and stent grafts in the peripheral vasculature.
Product codes
PNO
Device Description
The ULTRASCORE™ Focused Force PTA Balloon consists of a flexible, over-the-wire (OTW) catheter shaft with a semi-compliant balloon fixed at the distal end. For all balloon lengths, radiopaque markers delineate the working length of the balloon and aid in balloon placement. For balloon lengths of 100 mm and greater, two radiopaque markers are positioned on the distal portion of the balloon and one radiopaque marker is positioned on the proximal portion of the balloon to differentiate between the distal and proximal ends of the catheter includes an atraumatic tip to facilitate advancement of the catheter to and through the stenosis. Two scoring wires, oriented 180° apart, provide focused force upon dilatation. The ULTRASCORE™ Focused Force PTA Balloon is compatible with 0.014" or 0.035" guidewires, as denoted by the product labeling. The distal portion of the 0.014" guidewire compatible catheters is hydrophilically coated. The proximal portion of the catheter includes a female luer lock hub connected to the catheter with a guidewire lumen and an inflation lumen. Packaged with every product is a protective sheath that is positioned over the balloon and must be removed prior to use. A stylet is placed into the tip of the catheter. These products are not made with natural rubber latex.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
iliac, femoral, popliteal, infra-popliteal, and renal arteries; native or synthetic arteriovenous dialysis fistulae; peripheral vasculature
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
To demonstrate substantial equivalence of the subject device to the predicate device, its technological characteristics and performance criteria were evaluated. Using FDA Guidance Documents on non-clinical testing of medical devices and internal Risk Assessment procedures, the following in vitro tests were performed on the subject device: Reinsertion, Sheath Compatibility. The following in vitro biocompatibility testing was conducted in accordance with ISO 10993-1: 2009: Cytotoxicity, Sensitization, Intracutaneous Reactivity, Acute Systemic Toxicity, Hemocompatibility, Material Mediated Pyrogenicity, Thrombogenicity.
The subject device, the ULTRASCORE™ Focused Force PTA Balloon, met all predetermined acceptance criteria of design verification and validation as specified by applicable standards, guidance, test protocols and/or customer inputs.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
ULTRASCORE™ Focused Force PTA Balloon (K163420, Cleared June 14, 2017)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
Public Health Service
Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling a stylized eagle or bird in flight, composed of three overlapping human profiles.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 22, 2017
C.R. Bard, Inc. Mr. Jonathan Holmes Regulatory Affairs Associate 1625 W 3rd St Tempe, Arizona 85281
Re: K172571
Trade/Device Name: UltraScore Focused Force PTA Balloon Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: PNO Dated: August 25, 2017 Received: August 28, 2017
Dear Mr. Holmes:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Kenneth J. Cavanaugh -S
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K172571
Device Name UltraScore Focused Force PTA Balloon
Indications for Use (Describe)
The UltraScore Focused Force PTA Balloon is intended to dilate stenoses in the iliac, femoral, popliteal, infra-popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also recommended for post dilatation of balloon expandable stents, and stent grafts in the peripheral vasculature.
Type of Use (Select one or both, as applicable)
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
ULTRASCORE™ Focused Force PTA Balloon
510(k) Summary 21 CFR 807.92
As required by the Safe Medical Devices Act of 1990, coded under Section 513, Part (I)(3)(A) of the Food, Drug and Cosmetic Act, a 510(k) summary upon which substantial equivalence determination is based is as follows:
Submitter Information:
Bard Peripheral Vascular, Inc 1625 West 3rd Street Tempe, Arizona 85281
Phone: 480-350-6161 Fax: 480-449-2546
Contact Person: Jonathan Holmes, Regulatory Affairs Associate Date of Submission: August 24, 2017
Subject Device Name:
| Name of Device: | ULTRASCORE™ Focused Force PTA Balloon |
|---|---|
| Product Code: | PNO |
| Classification Name: | Catheter, Percutaneous, Cutting/Scoring |
| Regulatory Class: | Class II |
| Regulation Number: | 21 CFR 870.1250 |
| Predicate Device: | |
| Name of Device: | ULTRASCORE™ Focused Force PTA Balloon |
| (K163420, Cleared June 14, 2017) | |
| Product Code: | PNO |
| Classification Name: | Catheter, Percutaneous, Cutting/Scoring |
| Regulatory Class: | Class II |
Regulation Number: 21 CFR 870.1250
Image /page/3/Picture/13 description: The image shows the word "BARD" in a bold, sans-serif font. The letters are outlined in black, with a white fill. The "A" in "BARD" is stylized with a triangle shape at the top.
4
Device Description:
The ULTRASCORE™ Focused Force PTA Balloon consists of a flexible, over-the-wire (OTW) catheter shaft with a semi-compliant balloon fixed at the distal end. For all balloon lengths, radiopaque markers delineate the working length of the balloon and aid in balloon placement. For balloon lengths of 100 mm and greater, two radiopaque markers are positioned on the distal portion of the balloon and one radiopaque marker is positioned on the proximal portion of the balloon to differentiate between the distal and proximal ends of the catheter includes an atraumatic tip to facilitate advancement of the catheter to and through the stenosis. Two scoring wires, oriented 180° apart, provide focused force upon dilatation. The ULTRASCORE™ Focused Force PTA Balloon is compatible with 0.014" or 0.035" guidewires, as denoted by the product labeling. The distal portion of the 0.014" guidewire compatible catheters is hydrophilically coated. The proximal portion of the catheter includes a female luer lock hub connected to the catheter with a guidewire lumen and an inflation lumen. Packaged with every product is a protective sheath that is positioned over the balloon and must be removed prior to use. A stylet is placed into the tip of the catheter. These products are not made with natural rubber latex.
| Attribute | ULTRASCORE™ Focused Force PTA Balloon |
|---|---|
| Balloon Diameter (mm) | 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 6.0, 7.0, 8.0 |
| Balloon Length (cm) | 20, 40, 60, 80, 100, 120, 150, 200, 250, 300 |
| Catheter Shaft Length (cm) | 40, 75, 100, 130, 150 |
| .014" Platform Introducer Sheath | |
| Compatibility | 4F, 5F |
| .035" Platform Introducer Sheath | |
| Compatibility | 5F, 6F |
Indications for Use of Device:
The ULTRASCORE™ Focused Force PTA Balloon is intended to dilate stenoses in the illac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also recommended for post dilatation of balloon expandable stents, self-expanding stents, and stent qrafts in the peripheral vasculature.
Image /page/4/Picture/8 description: The image shows the word "BARD" in a bold, sans-serif font. The letters are all capitalized and appear to be a solid, dark color, possibly black or a dark gray. The font style is geometric and modern, with clean lines and a uniform thickness throughout each letter.
5
Comparison of Indications for Use to Predicate Device:
The indications for use statement for the ULTRASCORE™ Focused Force PTA Balloon is identical to that of the predicate device, and therefore does not raise any new issues of safety and effectiveness. Therefore, the subject device, the ULTRASCORE™ Focused Force PTA Balloon, is substantially equivalent to the predicate device.
Technological Comparison to Predicate Devices:
The ULTRASCORE™ Focused Force PTA Balloon is identical to the predicate device, the ULTRASCORE™ Focused Force PTA Balloon (clearance to market via K163420 on June 14, 2017) in the following ways:
- Same intended use ●
- o Same indications for use
- o Same target population
- o Same operating principle
- Same fundamental scientific technology o
- . Same sterility assurance level and method of sterilization
The following change has been made between the subject device and the predicate device:
- A new formulation of PTFE on the scoring wires has been qualified due to supplier . discontinuance of existing PTFE.
Image /page/5/Picture/15 description: The image shows the word "BARD" in a bold, sans-serif font. The letters are all capitalized and evenly spaced. The font is simple and modern, and the overall design is clean and professional. The image is likely a logo or branding element for a company or product named Bard.
6
Performance Data:
To demonstrate substantial equivalence of the subject device to the predicate device, its technological characteristics and performance criteria were evaluated. Using FDA Guidance Documents on non-clinical testing of medical devices and internal Risk Assessment procedures, the following in vitro tests were performed on the subject device:
- . Reinsertion
- Sheath Compatibility .
The following in vitro biocompatibility testing was conducted in accordance with ISO 10993-1: 2009
- Cytotoxicity
- o Sensitization
- o Intracutaneous Reactivity
- o Acute Systemic Toxicity
- o Hemocompatibility
- o Material Mediated Pyrogenicity
- o Thrombogenicity
Conclusions:
The subject device, the ULTRASCORE™ Focused Force PTA Balloon, met all predetermined acceptance criteria of design verification and validation as specified by applicable standards, guidance, test protocols and/or customer inputs. The ULTRASCORE™ Focused Force PTA Balloon is substantially equivalent to the legally marketed predicate device, ULTRASCORE™ Focused Force PTA Balloon.
Page 4 of 4
Image /page/6/Picture/17 description: The image shows the word "BARD" in a bold, sans-serif font. The letters are outlined in black, giving them a distinct and modern appearance. The overall design is simple and clean, focusing on the clarity and legibility of the word.